首页|术前D-NLR评分在不同分期卵巢癌的变化及其临床意义

术前D-NLR评分在不同分期卵巢癌的变化及其临床意义

扫码查看
目的 探讨术前D-二聚体和中性粒细胞与淋巴细胞比例(D-NLR)评分在不同分期卵巢癌的变化及其临床意义.方法 回顾性选取2012 年6 月至2023 年6 月在陕西中医药大学第二附属医院妇科经过手术治疗的卵巢癌患者269 例,根据国际妇产科联盟(International Federation of Gynecology and Obstetrics,FIGO)分期标准将其分为早期组(107 例)和晚期组(162 例),另选取同期接受手术治疗的 159 例卵巢良性肿瘤患者为良性组.根据ROC曲线,将D-二聚体和NLR的截断值分别设定为1.45 和2.46.然后将D-NLR评分分为 3 组:D-NLR评分 2 分组、1 分组、0分组.使用非参数检验和χ2 检验比较各组之间的连续变量和分类变量的差异.用Spearman秩相关检验来检验D-NLR评分与卵巢癌患者各项临床指标的相关性.结果 卵巢癌患者与卵巢良性肿瘤患者年龄、FIB、中性粒细胞计数、D-二聚体水平、血清CA125 水平≥35 U/mL的例数、绝经例数、NLR值比较,差异均有统计学意义(P<0.05).不同卵巢癌分期患者FIB、中性粒细胞计数、淋巴细胞计数、血小板计数、D-二聚体水平、血清CA125 水平≥35 U/mL的例数、PLR值、NLR值、腹水例数比较,差异均有统计学意义(P<0.05);D-NLR 评分与卵巢癌患者的 FIGO 分期、CA125、FBI呈显著的正相关(P<0.05),与年龄、是否绝经无明显相关性(P>0.05).结论 术前D-NLR评分是一种新的基于炎症的分级系统,其与卵巢癌的FIGO分期呈明显正相关,可作为判断卵巢癌分期的重要指标..
Preoperative D-NLR Score Variations Across Different Stages of Ovarian Cancer and Its Clinical Significance
Objective To investigate the changes and clinical significance of preoperative D-NLR(D-dimer to Neu-trophil-to-Lymphocyte Ratio)scores in ovarian cancer at different stages.Methods A retrospective study was conducted on 269 ovarian cancer patients who underwent surgical treatment in the gynecology department of the second affiliated hospital of Shaanxi university of chinese medicine June 2012 to June 2023.According to the International Federation of Gynecology and Obstetrics(FIGO)staging criteria,they were divided into an early stage group(107 cases)and a late stage group(162 ca-ses).Additionally,159 ovarian benign tumor patients who underwent surgical treatment during the same period were selected as the benign group..Based on the ROC curve,the cutoff values for D-dimer and NLR were set at 1.45 and 2.46,respec-tively.Subsequently,the D-NLR scores were categorized into three groups:D-NLR score 2,D-NLR score 1,and D-NLR score 0.Nonparametric tests and chi-square tests were used to compare differences in continuous and categorical variables a-mong the groups.Spearman's rank correlation test was employed to assess the correlation between D-NLR scores and various clinical indicators in ovarian cancer patients.Results Statistically significant differences were observed between ovarian cancer patients and those with benign ovarian tumors in terms of age,fibrinogen(FIB)levels,neutrophil counts,D-dimer levels,the number of cases with serum CA125 levels≥35 U/mL,the number of postmenopausal cases,and NLR values(P<0.05).Among patients with ovarian cancer at different stages,statistically significant differences were found in FIB levels,neutrophil counts,lymphocyte counts,platelet counts,D-dimer levels,the number of cases with serum CA125 levels≥35 U/mL,PLR values,NLR values,and the number of ascites cases(P<0.05).D-NLR scores were significantly positively corre-lated with FIGO stage,CA125,and FIB in ovarian cancer patients(P<0.05),but not significantly correlated with age or menopausal status(P>0.05).Conclusion Preoperative D-NLR score,a novel inflammation-based grading system,exhib-its a significant positive correlation with the FIGO stage of ovarian cancer and can serve as an important indicator for assessing ovarian cancer staging.

D-NLR ScoreOvarian CancerCorrelation

杜淑敏、李俊英、孟瑶、朱振宁、高卫华

展开 >

712000 咸阳,陕西中医药大学第二附属医院妇二科

723000 陕西汉中,汉中市中心医院产科

D-NLR评分 卵巢癌 相关性

2024

转化医学杂志
海军总医院

转化医学杂志

CSTPCD
影响因子:0.671
ISSN:2095-3097
年,卷(期):2024.13(7)